One of the main neuropathological hallmarks of Alzheimer’s disease (AD) is the accumulation of neurotoxic amyloid-beta oligomers (Aβo), which begins in the brain approximately 15 years prior to the onset of tau pathology, brain atrophy, memory decline, and the clinical diagnosis of AD.1 Here, MAPT is linked to Alzheimer disease.